anonymous
Guest
anonymous
Guest
SoldAre you thinking sold or going under?
SoldAre you thinking sold or going under?
Who would want to buy this company?Sold
Someone smart. Great deal right now. Hopefully soon!Who would want to buy this company?
Anyone know what’s going on? Lots of rumors about being sold. It makes sense, but who!?Someone smart. Great deal right now. Hopefully soon!
There is no way Allergan could buy Revance. Anti trust laws wouldn’t allow it.Rumor is Allergan
Those are my top two picks as well. Pfizer needs fresh growth trajectory and JNJ is sitting on $20B cash pile.Pfizer tried buying Allergan prior to Abbvie buying it - so I would bet they are looking at RVNC -
Johnson & Johnson owns Mentor Implants and would love to add to that portfolio to compete with Allergan
Lots of options for Aesthetic and Therpy use.
A sale at around $15-$18 a share would be helpful to everyone who has lost their shirts on this stock. RVNC also needs more tenured sales leadership & marketing team to make a dent, Foley needs to get out before he sinks this ship like the titanic. His legacy will now be this failure because no one will remember the old sale of Coolsculpting to Allergan.... too many poor decisions at this company.
This would be a nightmareI heard Prollenium is not getting Hugel so there is a risk they may look at us. If that happens it will be a painful end for Revance. Can you imagine working for that stupid man?
Fingers crossed it will be one of your other bets and then there will be a future for us.
Interesting perspectiveIt could also be Huadong or Fosun. Huadong acquired Sinclair and is looking to enter the US market. Fosun has acquired the rights of Daxxify in China. Both companies with substantial cash.
Somebody saves us, please. Let’s go, Pfizer!!!!If we get sold to Prollenium we will think about this current mess as a good thing. Didn’t think things could get worse, but the Prollenium option would be a disaster.
Why would the FDA shut them down?Prollenium is not going to happen. FDA may shut them down soon.
Pfizer and J&J are viable options.
I don’t think they will lay off salesforce, at least not in the beginning.
the “loyalty” bonusProllenium is not going to happen. FDA may shut them down soon.
Pfizer and J&J are viable options.
I don’t think they will lay off salesforce, at least not in the beginning.